UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

On May 4, 2020, in light of the economic uncertainty stemming from the COVID-19 pandemic and to mitigate any financial impact to the Company related to the pandemic, the Board of Directors (the “Board”) of Transcat, Inc. (the “Company”) approved temporary reductions to the base salary of certain of the Company’s officers. Effective as of April 1, 2020 and until such time as the Board determines to reinstate such salaries in full or part, the President and Chief Executive Officer’s base salary is reduced by 20% and the other named executive officers’ base salaries are reduced by 10%. The Company’s President and Chief Executive Officer agreed that this temporary reduction in his base salary does not constitute a “Material Change” under his Agreement for Severance Upon Change in Control with the Company.

Further, to support the Company’s cost reduction initiatives in response to the COVID-19 pandemic, the Board agreed to defer cash retainer fees for director services payable in the first quarter of fiscal 2021 until the earlier of payment of the annual performance-based cash incentive compensation to officers of the Company or December 31, 2020. The Board also agreed to reduce the cash retainer fees for directors, including additional cash retainer fees for chairpersons of each committee and the executive committee of the Board, by 20% until such time as the Board determines to reinstate such amounts in full or part.

Item 7.01 Regulation FD Disclosure.

On May 8, 2020, the Company posted slides to the Investor Relations section of its website that will accompany the Company’s presentation for the Oppenheimer 5th Annual Emerging Growth Conference on May 12, 2020. The slides are attached to this Form 8-K as Exhibit 99.1.

The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under such section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.